Skip to main content
Clinical Trials/ACTRN12616000172404
ACTRN12616000172404
Completed
Phase 4

A Prospective Multicentre Randomized Controlled Trial of Standard Compared to Surgery Specific Goal-directed Therapy (GDT) for Patients UndergoingMajor Liver Resection

Austin Hospital0 sites48 target enrollmentFebruary 11, 2016

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
liver cancer
Sponsor
Austin Hospital
Enrollment
48
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 11, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Austin Hospital

Eligibility Criteria

Inclusion Criteria

  • All patients (age \> 18 years) undergoing liver resection

Exclusion Criteria

  • 1\. Age less than 18 years
  • 2\. Abnormal pre\-operative coagulopathy: INR (international normalised ratio) \> 1\.5, platelet count \< 75 x 109/l
  • 3\. Severe hepatic insufficiency (bilirubin \> 30umol/L, ALP (alkaline phosphatase) \>300iu/L, ALT (alanine transaminase) \> 50iu/L, albumin \< 25g/dL, INR \> 1\.5\)
  • 4\. Severe renal impairment: Serum Creatinine \>250ummol/L
  • 5\. American Society of Anaesthesiologists (ASA) physical status IV or V

Outcomes

Primary Outcomes

Not specified

Similar Trials